In a quiet corner of modern medicine, a mother fights for her dying son's access to a drug that exists but remains just out of reach — held behind walls of policy, profit, and process. Rare cancers expose a fundamental tension in how societies organize care: systems built for the many leave the few without a door to knock on. This family's struggle is not an anomaly but a symptom, a single visible thread in a much larger unraveling of what medicine promises and what it delivers.
Mother's Fight to Access Rare Cancer Drug for Dying Son
A child with a rare, terminal cancer faces delayed access to potentially life-saving medication.